Needham raised the firm’s price target on Alnylam (ALNY) to $529 from $520 and keeps a Buy rating on the shares after its Q4 pre-announcement and FY26 guidance. The firm anticipates the Amvuttra launch in TTR-CM will be a key driver for Alnylam shares in 2026, also noting that the initial revenue guide is highly encouraging and provides some additional room for potential upside, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALNY: